An incomplete form of childhood Behçet's disease treated with infliximab.

Caporuscio, S; Pranteda, G; Nistico, S; Maucione, T; Canzoni, M; Stefani, A; Muscianese, M; Fanto, M; Sorgi, M

Caporuscio, S; Pranteda, G; Nistico, S; Maucione, T; Canzoni, M; Stefani, A; Muscianese, M; Fanto, M; Sorgi, M.

Afiliação

Caporuscio S; Division of Rheumatology, Department of Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Pranteda G; Division of Dermatology, Department of Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Nistico S; Unit of Dermatology, University of Catanzaro, Italy.
Maucione T; Sapienza University of Rome, Rome, Italy.
Canzoni M; Division of Rheumatology, Department of Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Stefani A; Division of Rheumatology, Department of Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Muscianese M; Division of Rheumatology, Department of Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Fanto M; Division of Rheumatology, Department of Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.
Sorgi M; Division of Rheumatology, Department of Medicine, Sapienza University of Rome, Sant'Andrea Hospital, Rome, Italy.

Int J Immunopathol Pharmacol ; 27(3): 445-8, 2014.

Article em En | MEDLINE | ID: mdl-25280037

Assuntos

Anticorpos Monoclonais/uso terapêutico; Síndrome de Behçet/tratamento farmacológico; Adolescente; Síndrome de Behçet/diagnóstico; Síndrome de Behçet/patologia; Humanos; Infliximab; Masculino

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Behçet / Anticorpos Monoclonais Tipo de estudo: Diagnostic_studies Limite: Adolescent / Humans / Male Idioma: En Revista: Int J Immunopathol Pharmacol Ano de publicação: 2014 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links